cenpl Antibody

What is CENPL and why is it significant in cancer research?

CENPL is a component of the centromere-kinetochore complex essential for proper chromosome segregation during cell division. Recent research has identified CENPL as a potential biomarker and oncogene in numerous cancer types, particularly lung adenocarcinoma (LUAD) . The protein plays critical roles in kinetochore assembly, chromosome alignment, and cell cycle progression. Its dysregulation has been linked to genomic instability, a hallmark of cancer development. When investigating CENPL expression, researchers should employ multiple detection methods, including immunohistochemistry (IHC) for tissue localization and Western blotting for quantitative analysis, while comparing expression between tumor and matched normal samples for accurate assessment.

What applications are CENPL antibodies most commonly used for?

CENPL antibodies support multiple experimental applications crucial for comprehensive molecular and cellular investigation. The primary methodological applications include:

• Western Blotting (WB): For quantitative assessment of CENPL protein expression

• Immunohistochemistry (IHC): For visualization of CENPL in tissue sections

• Immunocytochemistry (ICC) and Immunofluorescence (IF): For subcellular localization studies

• Immunoprecipitation (IP): For isolation of CENPL-containing protein complexes

• Flow Cytometry (FCM): For analysis of CENPL at the single-cell level

When selecting antibodies, researchers should prioritize those validated for their specific application of interest, as performance can vary substantially across different techniques . For cancer research applications, antibodies validated specifically in relevant tumor types will provide the most reliable results.

How do I validate the specificity of a CENPL antibody?

Validating CENPL antibody specificity requires a systematic approach incorporating multiple complementary methods. Begin with positive and negative control samples with known CENPL expression levels. For definitive validation, perform genetic knockdown experiments using siRNA or CRISPR-Cas9 technology targeting CENPL, which should result in corresponding signal reduction . Peptide competition assays, where pre-incubation with the immunizing peptide abolishes specific binding, provide additional confirmation. Cross-reactivity with other centromere proteins should be evaluated due to sequence homology within this protein family. Western blot analysis should confirm detection at the expected molecular weight, while immunofluorescence should demonstrate the characteristic centromeric/nuclear localization pattern. When possible, compare multiple antibodies targeting different CENPL epitopes to build confidence in observed patterns.

What experimental controls are essential when working with CENPL antibodies?

Proper experimental controls are critical for generating reliable data with CENPL antibodies. For immunostaining applications (IHC, ICC, IF), include isotype controls matched to the primary antibody's host species and concentration to assess non-specific binding . In knockdown experiments, implement both scrambled siRNA controls and partial knockdowns to establish dose-dependent relationships . For tissue analyses, always include matched normal adjacent tissue as primary controls. Cell cycle synchronization is particularly important when studying centromere proteins like CENPL, as their expression and localization fluctuate during mitosis. When analyzing cancer cell lines, include both transformed non-cancerous cells and a panel of cancer cell lines with varying CENPL expression levels to capture biological diversity. For analyzing protein-protein interactions, include both negative controls (irrelevant antibodies) and positive controls (known interacting partners) in co-immunoprecipitation experiments.

How does CENPL expression correlate with immune cell infiltration in the tumor microenvironment?

CENPL expression demonstrates distinct patterns of correlation with immune cell infiltration across multiple cancer types. Comprehensive analysis using TIMER 2.0 revealed significant associations with both immunosuppressive and anti-tumor immune populations. The data shows:

Table 1: CENPL expression correlation with immune cell infiltration in selected cancer types

In lung adenocarcinoma specifically, CENPL shows negative correlations with multiple anti-tumor immune cell populations:

Table 2: CENPL expression correlation with immune cell infiltration in LUAD

These findings suggest CENPL may promote an immunosuppressive microenvironment by encouraging MDSC accumulation while inhibiting anti-tumor immune cell recruitment . To validate these computational findings, researchers should conduct multiplex immunohistochemistry or flow cytometry on fresh tumor samples to directly quantify immune populations in relation to CENPL expression.

What is the relationship between CENPL expression and MHC molecules in cancer?

CENPL expression demonstrates significant negative correlations with multiple MHC molecules in cancer, particularly in lung adenocarcinoma. This relationship suggests CENPL may influence antigen presentation capability within the tumor microenvironment.

Table 3: Correlation between CENPL and MHCs in LUAD

The consistent negative correlation pattern across multiple MHC molecules suggests a potential mechanism by which high CENPL expression may contribute to immune evasion in tumors . To experimentally validate this relationship, researchers should perform CENPL knockdown or overexpression experiments in cancer cell lines, followed by flow cytometric analysis of MHC surface expression. Additionally, chromatin immunoprecipitation sequencing (ChIP-seq) could reveal whether CENPL directly or indirectly regulates MHC gene expression. Co-culture experiments with T cells would determine if CENPL-mediated MHC downregulation functionally impairs antigen presentation and T cell activation.

How does CENPL knockdown affect cell cycle progression and apoptosis in cancer cells?

CENPL knockdown significantly disrupts cell cycle progression in cancer cells and promotes apoptosis. In lung adenocarcinoma cell lines, siRNA-mediated CENPL knockdown induces G0/G1 cell cycle arrest, preventing progression to S phase . This arrest correlates with downregulation of key cell cycle regulators, particularly CDK2 (cyclin-dependent kinase 2) and CCNE2 (cyclin E2) . Additionally, CENPL depletion increases apoptosis rates in these cancer cells, suggesting it may be essential for cancer cell survival.

For rigorous experimental assessment of these phenotypes, researchers should:

• Use flow cytometry with propidium iodide staining for cell cycle analysis

• Perform Annexin V/PI dual staining for apoptosis quantification

• Conduct Western blotting to monitor changes in cell cycle regulators and apoptotic markers

• Implement time-course experiments (24, 48, and 72 hours post-knockdown) to distinguish primary from secondary effects

• Include rescue experiments with exogenous CENPL expression to confirm specificity

These findings highlight CENPL as a potential therapeutic target, as its inhibition simultaneously blocks proliferation and promotes cell death in cancer cells.

What is the relationship between CENPL and chemokine receptors in the tumor microenvironment?

CENPL expression demonstrates significant negative correlations with multiple chemokine receptors in lung adenocarcinoma, suggesting a potential mechanistic link to altered immune cell recruitment.

Table 4: Correlation between CENPL and chemokine receptors in LUAD

The strong negative correlation with CX3CR1 is particularly noteworthy, as this receptor mediates NK cell and T cell trafficking . Similarly, the negative association with CCR7 suggests potential impairment of dendritic cell and T cell migration to lymph nodes, which could inhibit proper immune priming. To experimentally investigate these relationships, researchers should analyze chemokine receptor expression following CENPL modulation in both tumor cells and immune cells. Transwell migration assays can assess if CENPL-mediated changes in chemokine receptor expression functionally alter immune cell recruitment. In vivo studies using CENPL-depleted tumors would further reveal if chemokine receptor modulation translates to altered immune infiltration patterns.

How does CENPL functionally interact with cell cycle regulators?

CENPL exhibits strong positive correlations with multiple cell cycle regulators, suggesting coordinated expression and potential functional interactions in regulating cell proliferation.

Table 5: Correlation between CENPL and cell cycle regulators

Experimental evidence has demonstrated that CENPL knockdown significantly reduces expression of CDK2 and CCNE2, directly contributing to G0/G1 cell cycle arrest in cancer cells . These findings establish CENPL as a potential upstream regulator of these key cell cycle components. To thoroughly investigate these relationships, researchers should:

• Perform co-immunoprecipitation experiments to detect physical interactions between CENPL and cell cycle proteins

• Use proximity ligation assays for in situ visualization of protein-protein interactions

• Conduct ChIP-seq analysis to determine if CENPL plays a direct role in regulating cell cycle gene expression

• Implement sequential knockdown/overexpression experiments to establish epistatic relationships between CENPL and key cell cycle regulators

• Analyze synchronized cell populations to determine temporal dynamics of these relationships during cell cycle progression

Understanding these functional interactions could reveal novel approaches for targeting cell cycle dysregulation in cancer.

What techniques are most effective for studying CENPL in cancer tissues?

Comprehensive CENPL analysis in cancer tissues requires integration of multiple complementary techniques. Immunohistochemistry using validated CENPL antibodies provides crucial spatial information and enables correlation with histopathological features . For quantitative assessment, tissue microarrays allow high-throughput screening across large patient cohorts. Multiplex immunofluorescence enables simultaneous visualization of CENPL with other markers, particularly immune cell populations to validate computational correlation findings . Laser capture microdissection combined with RT-qPCR or proteomic analysis allows region-specific CENPL profiling within heterogeneous tumors. In situ hybridization techniques provide additional validation at the mRNA level. For functional studies in patient-derived models, organoid cultures or xenografts combined with CENPL manipulation offer clinically relevant systems. Each method should include rigorous controls: isotype antibodies for immunostaining, matched normal tissues for expression comparisons, and multiple antibody validation approaches to ensure specificity.

How can apparent contradictions in CENPL expression data be resolved?

Interpreting contradictory results in CENPL expression studies requires systematic evaluation of multiple variables. First, assess methodological differences: antibody clones may have varying specificities ; primer designs for qPCR may target different transcript variants; and protein extraction protocols might differentially solubilize nuclear-associated proteins like CENPL. Second, examine sample characteristics: contradictions often arise from differences in cancer subtypes, stages, treatment histories, or patient demographics. Third, evaluate normalization approaches, particularly for transcriptomic data where reference gene selection impacts results.

Resolution strategies include:

• Multi-platform validation combining RNA-seq, qPCR, Western blot, and IHC

• Stratification of analyses by clinically relevant subgroups

• Single-cell approaches to resolve cellular heterogeneity issues

• Meta-analyses across studies with standardized reporting

• Implementation of antibody validation consortia standards for reproducibility

Researchers should explicitly report all methodological details, including antibody clones, dilutions, incubation conditions, and validation procedures to enable meaningful cross-study comparisons .